Atomic Force Microscopy - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Atomic Force Microscopy
An analytical technique that is receiving increased attention in the pharmaceutical industry is atomic force microscopy. We interview Mark Leaper from the UK's De Montfort University to find out more about this technology.

Pharmaceutical Technology Europe

How can characterisation of the morphology and roughness of pharmaceutical granules using atomic force microscopy result in improved granulation and pharmaceutical processing?

The flow properties of a powder can be influenced by the shape and roughness of the particles. A thorough knowledge of the surface properties of excipient powders and the resulting granules will enable process parameters to be optimised. It will also be helpful when modifying process methods, for example, a switch from wet granulation to dry granulation or direct compression. Rough particles also have a greater surface area, allowing the absorption of more moisture. This may be desirable or undesirable, depending on the application of the powder.

How might AFM be applied to the measurement of dynamic rheological properties, to benefit characterisation of a pharmaceutical formulation?

AFM can be used in liquids, and there have been several studies of suspensions and colloids in which AFM has been used to measure interactions between particles, as well as between the particles and fluid. There have also been studies that have examined the formation of bubbles in liquids and their interaction with particles in the suspension. AFM could be used to complement other techniques in optimising the design and manufacture of pharmaceutical suspensions, creams and lotions. In addition to the properties of the drug delivery systems, AFM can be used to characterise the areas to which the formulations are applied, such as skin, hair or dressing.

Are there any knowledge or technological gaps in the pharma industry that prevent AFM from being fully exploited?

The techniques and research strategies for using AFM in the pharma industry are now well established: examining the properties of powdered excipients, colloids, pulmonary drug delivery, microbiological systems and implants. The volume of data is still limited, however, and has not kept pace with the new formulations. As manufacturing companies modify their practices to accommodate the new quality by design approach, AFM will have a part to play. Along with bulk powder techniques, knowledge of the variation of surface properties will enable optimisation of solid-dosage manufacturing processes.

Mark Leaper is Senior Lecturer, School of Pharmacy,De MontfortUniversity (UK).


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans
Source: Pharmaceutical Technology Europe,
Click here